---
title: "Yatai Pharm: The cumulative deviation of the stock price increase over the past two days exceeds 20%, warning of risks"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263969858.md"
description: "Yatai Pharm announced that the cumulative deviation of the stock price increase on October 31 and November 3, 2025, exceeded 20%, indicating abnormal fluctuations. The controlling shareholder, Fubon Group, intends to transfer 14.61% of its shares, and the actual controller will change to Qiu Zhongxun. The company also plans to conduct a private placement to Xinghao Holdings, which constitutes a related party transaction. Both matters carry uncertainties, and investors are reminded to pay attention to risks"
datetime: "2025-11-03T08:50:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263969858.md)
  - [en](https://longbridge.com/en/news/263969858.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263969858.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/263969858.md) | [繁體中文](https://longbridge.com/zh-HK/news/263969858.md)


# Yatai Pharm: The cumulative deviation of the stock price increase over the past two days exceeds 20%, warning of risks

Yatai Pharm announced that the closing price of the company's stock on October 31 and November 3, 2025, had a cumulative deviation of over 20% for two consecutive trading days, which constitutes abnormal fluctuations. After verification, there are no corrections or supplements to the previously disclosed information, and there have been no significant changes in recent operations and environment. On October 13, 2025, the controlling shareholder Fubon Group and its concerted parties plan to transfer 14.61% of shares, totaling 108,945,566 shares, for a total price of 900 million yuan, after which the actual controller will change to Qiu Zhongxun. In addition, the company plans to conduct a private placement to Xinghao Holdings, which constitutes a related party transaction. Both matters carry uncertainties, and investors are reminded to pay attention to risks

### Related Stocks

- [Yatai pharm (002370.CN)](https://longbridge.com/en/quote/002370.CN.md)

## Related News & Research

- [Clover Biopharmaceuticals Sets Board Meeting to Approve 2025 Results and Consider Dividend](https://longbridge.com/en/news/279032574.md)
- [Kennedy Center President Grenell to transition out of his role, Axios reports](https://longbridge.com/en/news/279085698.md)
- [Know a rising star in pharma marketing? Nominate them here](https://longbridge.com/en/news/278461777.md)
- [Malaysia’s IJM board calls Sunway's $2.8 billion takeover bid 'not fair', urges rejection](https://longbridge.com/en/news/279023547.md)
- [IFW Dresden selects Agnitron Agilis 100 MOCVD platform for precursor chemistry and ultra-wide-bandgap materials development](https://longbridge.com/en/news/279074236.md)